V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160012365 | 160005930 | 1.62 | 99.9 | Curative (C) | 2018-11-03 | 2018-11-03 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100655541 |
| 160012371 | 160005931 | null | null | Curative (C) | 2018-04-23 | 2018-05-18 | Pemetrexed | 02 | N | STS RHABDO RMS 2005 VIN CYCLO | 101140575 |
| 160012372 | 160005932 | 1.6 | 81.4 | Curative (C) | 2018-03-19 | 2018-04-30 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100676178 |
| 160012373 | 160005933 | 1.62 | 61 | Palliative (P) | 2019-05-11 | 2019-06-14 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 100782159 |
| 160012375 | 160005934 | 1.56 | 67.2 | Palliative (P) | 2019-08-04 | 2019-08-09 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 101188283 |
| 160012378 | 160005935 | 1.77 | 113.1 | Palliative (P) | null | 2014-12-12 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | ETOP 13-18 BEAT-MESO TRIAL | 100449548 |
| 160012379 | 160005936 | 1.57 | 85 | Palliative (P) | 2019-04-02 | 2019-04-07 | ETOP 13-18 BEAT-meso Trial | 02 | N | TRABECTEDIN | 101816667 |
| 160012383 | 160005937 | 1.62 | 71.65 | null | 2019-11-20 | 2019-11-22 | Enzalutamide | 02 | null | PACLITAXEL | 101083907 |
| 160012384 | 160005938 | 0 | 0 | Palliative (P) | 2018-05-20 | 2018-05-30 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100345708 |
| 160012385 | 160005939 | null | null | Palliative (P) | 2016-11-17 | 2016-11-17 | Carboplatin AUC 2 - 5 | 02 | null | VIDE | 100052544 |
| 160012387 | 160005940 | 1.82 | 50.5 | Palliative (P) | 2019-06-06 | 2019-06-07 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100395877 |
| 160012388 | 160005941 | 1.71 | 72 | Palliative (P) | 2021-02-26 | 2021-03-19 | Cisplatin + Pemetrexed | 01 | null | CISPLATIN + PEMETREXED | 100907001 |
| 160012389 | 160005942 | 1.54 | 89.1 | Palliative (P) | 2018-06-05 | 2018-06-06 | Letrozole + Palbociclib | 2 | N | TRIAL UNSPECIFIED | 101404853 |
| 160012390 | 160005943 | 1.59 | 80 | Palliative (P) | 2020-10-31 | 2020-11-01 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100369243 |
| 160012392 | 160005944 | null | null | null | 2019-09-10 | 2019-09-13 | Carboplatin AUC 2 - 5 | 02 | null | DACTINOMYCIN + VINCRISTINE | 101814473 |
| 160012393 | 160005945 | 1.76 | 79.6 | Palliative (P) | 2018-07-25 | 2018-07-30 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100027831 |
| 160012395 | 160005946 | 0 | 12.5 | Neo-adjuvant (N) | 2018-05-10 | 2018-05-11 | NB Low/Interm risk guidelines Carbo/Etop | N | N | PEMETREXED | 101567341 |
| 160012397 | 160005947 | 1.73 | 69.8 | Palliative (P) | 2017-08-10 | 2017-08-10 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 100623565 |
| 160012398 | 160005948 | 1.76 | 88.6 | Curative (C) | 2018-03-12 | 2018-03-22 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100102306 |
| 160012399 | 160005949 | 1.64 | 91 | Neo-adjuvant (N) | 2016-02-12 | 2016-02-26 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100963198 |
| 160012401 | 160005950 | 1.87 | 107.6 | Palliative (P) | 2022-03-30 | 2022-04-03 | VIP | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100132385 |
| 160012404 | 160005951 | 1.89 | 90.1 | Palliative (P) | 2020-03-30 | 2020-04-04 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101442542 |
| 160012405 | 160005952 | 1.8 | 72.8 | Palliative (P) | 2016-07-06 | 2016-07-17 | Abiraterone | 02 | N | VIDE | 100236706 |
| 160012407 | 160005953 | null | null | Curative (C) | 2017-02-08 | 2017-02-08 | IVADo | 02 | null | CISPLATIN + DOXORUBICIN | 101755774 |
| 160012411 | 160005954 | 1.81 | 121.4 | Palliative (P) | 2018-12-26 | 2018-12-27 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101722548 |
| 160012412 | 160005955 | 0 | 91.6 | Palliative (P) | null | 2020-01-18 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100942543 |
| 160012414 | 160005956 | 1.73 | 67.6 | Neo-adjuvant (N) | 2017-02-08 | 2017-02-22 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100137001 |
| 160012415 | 160005957 | 1.81 | 63.5 | Palliative (P) | 2016-09-04 | 2016-09-12 | DOXORUBICIN | 01 | N | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 100805216 |
| 160012417 | 160005958 | 1.71 | 50.8 | Palliative (P) | 2019-04-11 | 2019-04-14 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100748414 |
| 160012418 | 160005959 | 1.75 | 80 | Palliative (P) | 2017-09-23 | 2017-09-29 | Doxorubicin + Ifosfamide | N | N | PACLITAXEL | 100309166 |
| 160012419 | 160005960 | 1.54 | 82.8 | Palliative (P) | 2018-12-02 | 2018-12-02 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100950679 |
| 160012421 | 160005961 | 0 | 35.8 | Neo-adjuvant (N) | 2017-01-07 | 2017-01-28 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100521053 |
| 160012423 | 160005962 | 0 | 0 | null | 2020-06-16 | 2020-06-24 | GC Int Guide Excranial GermCell JEB | null | N | RITUXIMAB | 100387607 |
| 160012424 | 160005963 | 1.7 | 102.5 | Neo-adjuvant (N) | null | 2019-11-12 | Doxorubicin + Olaratumab | 02 | N | VINBLASTINE | 101859620 |
| 160012426 | 160005964 | 1.82 | 100 | Neo-adjuvant (N) | 2019-02-05 | 2019-02-25 | Trial Unspecified | N | N | TRIAL UNSPECIFIED | 100152789 |
| 160012427 | 160005965 | 1.56 | 66.1 | null | 2020-07-19 | 2020-07-31 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | Y | CARBOPLATIN | 101683542 |
| 160012428 | 160005966 | 1.14 | 77.3 | Palliative (P) | 2017-05-19 | 2017-05-30 | Cisplatin + Pemetrexed | Y | Y | CISPLATIN + PEMETREXED | 100957284 |
| 160012431 | 160005967 | 1.85 | 61 | null | 2018-04-05 | 2018-04-11 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100946708 |
| 160012432 | 160005968 | 1.74 | 100 | Adjuvant (A) | 2017-02-17 | 2017-03-03 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100676006 |
| 160012433 | 160005969 | 1.88 | 97.8 | Palliative (P) | 2018-02-26 | 2018-03-07 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100019810 |
| 160012434 | 160005970 | 1 | 69.8 | Palliative (P) | 2019-10-24 | 2019-10-30 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101249719 |
| 160012436 | 160005971 | 1.63 | 61.3 | Neo-adjuvant (N) | 2019-11-13 | 2019-11-15 | Liposomal Doxorubicin (Caelyx) | null | N | BEP | 100364732 |
| 160012441 | 160005972 | null | 61.2 | Palliative (P) | 2017-07-06 | 2017-07-14 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101532622 |
| 160012442 | 160005973 | 1.57 | 99 | Palliative (P) | 2017-01-09 | 2017-01-11 | Carboplatin + Paclitaxel (weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101564457 |
| 160012443 | 160005974 | 1.69 | 86 | Palliative (P) | 2019-05-31 | 2019-06-22 | Cetuximab + FOLFIRI cycle1 | 02 | N | IMATINIB | 100375976 |
| 160012444 | 160005975 | 1.6 | 65.9 | Palliative (P) | 2019-03-09 | 2019-04-01 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100226843 |
| 160012447 | 160005976 | 1.77 | 84.7 | Palliative (P) | null | null | LENVATINIB | 02 | N | VIDE | 101611569 |
| 160012449 | 160005977 | 1.52 | 90.5 | Curative (C) | 2017-03-13 | 2017-03-22 | EW EuroEwing 2012 Arm A VIDE | 02 | N | TRIAL UNSPECIFIED | 101120772 |
| 160012450 | 160005978 | 1.68 | 97 | Palliative (P) | 2017-08-17 | 2017-08-29 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | PEMETREXED | 100023901 |
| 160012452 | 160005980 | 1.7 | 60.55 | Neo-adjuvant (N) | 2018-01-16 | 2018-02-14 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101863030 |